Exposure to breast milk triclosan and parabens and eczema phenotypes at 12 months: A nested case-control study
Adrian J Lowe, Xianyu Wang, Jochen F Mueller, Michael J Abramson, Ruby Y Yeh, Bircan Erbas, Shyamali C Dharmage, Caroline J Lodge
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | MOSBY-ELSEVIER | Published : 2019
Levels of butyl-paraben in breastmilk at three months were associated with increased risk of atopic-eczema at 12 months of age, potentially due to altered gut microbiome.
The first 6 years of the Melbourne Atopy Cohort Study (MACS) were funded (study formula and staff) by Nestec Ltd, a subsidiary of Nestle Australia. The University of Melbourne provided funds through an internal grant scheme to allow the assessment of breast milk parabens and triclosan for this study. All bodies that have funded aspects of the MACS have had no role in interpretation and publication of study findings.